Diabetes Type 1

riva greenberg.JPG
Pointed Conversations: Thriving with Diabetes

 

Riva Greenberg

Riva Greenberg is passionate about helping patients living with diabetes to life a better life not despite—but because of—their diagnosis.

Update on Worldwide Trends in

Occurrence of Childhood Type 1

Diabetes in 2020

 

Jaakko Tuomilehto, MD, MA, PhD, FRCP (Edin), Graham D. Ogle, MBBS,

FRACP, Nicolai A. Lund-Blix, MSc, PhD, Lars C Stene, MSc, PhD

Epidemiologic research aims at describing and analysing

the occurrence of a disease, its determinants and its consequences at the population level. Epidemiological

methods can be used for the assessment of the efficacy and effectiveness of preventive interventions, either primary,

secondary or tertiary.

riva greenberg.JPG
Pointed Conversations: Advocating for Yourself

 

Riva Greenberg

Riva Greenberg is passionate about helping patients living with diabetes to life a better life not despite—but because of—their diagnosis.

Randomized 52-weekPhase 2 Trial of Albiglutide Versus Placebo in Adult Patients With Newly Diagnosed Type 1 Diabetes

 

Paolo Pozilli, Emanuele Bosi, Deborah Cirkel, Julia Harris, Nicola Leech, Francisco J. Tinahones, Marie-Christine Vantyghem, Georgios Vlasakakis, Anette-Gabriele Ziegler, and Salim Janmohamed

Context: GLP-1 receptor agonists are an established therapy in patients with type 2 diabetes; however, their role in type 1 diabetes remains to be determined.
Objective: Setermine 
efficacy and safety of once-weekly albiglutide 30 mg (up-titration to 50 mg at week 6) versus placebo together with insulin in patients with new-onset type-1 diabetes and residual insulin production.

Hypoglycaemia and its management in primary care setting

 

Mahmoud Ibrahim, Jason Baker, Avivit Cahn, Robert H. Ecke, Nuha Ali El Sayed, Amy Hess Fischl, Peter Gaede, R. David Leslie, Silvia Pieralice, Dario Tuccinardi, Paolo Pozzilli, Bjørn Richelsen, Eytan Roitman, Eberhard Stand, Yoel Toledano, Jaakko Tuomilehto, Sandra L. Weber, Guillermo E. Umpierrez

Hypoglycaemia is common in patients with type 1 diabetes and type 2 diabetes and constitutes a major limiting factor in achieving glycaemic control among people with diabetes. While hypoglycaemia is defined as a blood glucose level under 70 mg/dL

(3.9 mmol/L), symptoms may occur at higher blood glucose levels in individuals with poor glycaemic control.

Hypoglycaemia and its management in primary care setting

Mahmoud Ibrahim, Jason Baker, Avivit Cahn, Robert H. Eckel, Nuha Ali El Sayed, Amy Hess Fischl, Peter Gaede, R. David Leslie, Silvia Pieralice, Dario Tuccinardi, Paolo Pozzilli, Bjørn Richelsen, Eytan Roitman, Eberhard Standl, Yoel Toledano, Jaakko Tuomilehto, Sandra L. Weber, Guillermo E. Umpierrez17

The American Diabetes Association (ADA) defined hypoglycaemia in

diabetes as any episode of an abnormally low plasma glucose concentration that exposes the individual to potential harm.2 This nonnumerical

definition was based on the facts that glycaemic thresholds for responses to hypoglycaemia vary among individuals and within the same individual.
Also, there is no specific glucose concentration that defines hypoglycaemia in diabetes.

© 2020 by CGEF. Design: TALIA DESIGN

  • Grey Pinterest Icon
  • Grey Instagram Icon
  • Grey LinkedIn Icon
  • Grey Facebook Icon
  • Grey Twitter Icon